Aflatoxin B1 exposure monitoring via the determination of urinary aflatoxin M1 in pregnant women, lactating women, and infants—a review of methods

Aflatoxin B1 (AFB1), a carcinogen produced by Aspergillus species, frequently contaminates poorly stored staples mainly in resource-limited settings including sub-Saharan Africa, South East Asia, and Latin America. AFB1 remains a global concern for human health and food security. Vulnerable populations including pregnant women and lactating women are exposed to AFB1 via contaminated diets while infants are exposed via breast milk, complementary and/or weaning foods including maize and peanuts. Recent AFB1 exposure is reflected by the presence of aflatoxin M1 (AFM1) in urine. We aimed to review methods applied in AFB1 exposure monitoring via the determination of urinary AFM1 in pregnant women, lactating women, and infants aged ≤24 months. We retrieved 9, 6, and 15 studies of pregnant women, lactating women, and infants, respectively. Urinary AFM1 was determined via high-performance liquid chromatography (HPLC) and liquid chromatography tandem mass spectrometry (LC–MS/MS) in 23% and 33% of studies, respectively. The HPLC- and LC–MS/MS-based methods involved extensive sample preparation and required technical expertise and very expensive equipment. ELISA, a simple, commercially available, reasonably priced and rapid technology, was used to determine urinary AFM1 in 40% of studies. Several major challenges and pitfalls must be addressed to achieve reliable and standardized data. The challenges include sample size, study design, collection, transportation, and storage of urine, reporting of AFM1 concentration either in crude form or after adjusting for creatinine concentration; and analytical issues including matrix effects, recovery, reproducibility, and limit of detection. The development of accessible, validated analytical methods, and guidelines for the determination of urinary AFM1 is warranted to achieve reliable and standardized data.

Authors

Publication Details

Journal
Figshare
Published
2026-11-17
DOI
https://doi.org/10.6084/m9.figshare.35040389
Primary Topic
Mycotoxins in Agriculture and Food
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Aflatoxin B1 exposure monitoring via the determination of urinary aflatoxin M1 in pregnant women, lactating women, and infants—a review of methods

Tatenda Clive Murashiki, Regis Rufaro Beta, Cathrine Chidewe
2 links
Figshare
Mycotoxins in Agriculture and Food
article

Aflatoxin B1 exposure monitoring via the determination of urinary aflatoxin M1 in pregnant women, lactating women, and infants—a review of methods

Tatenda Clive Murashiki, Regis Rufaro Beta, Cathrine Chidewe
article en

Abstract

Aflatoxin B1 (AFB1), a carcinogen produced by Aspergillus species, frequently contaminates poorly stored staples mainly in resource-limited settings including sub-Saharan Africa, South East Asia, and Latin America. AFB1 remains a global concern for human health and food security. Vulnerable populations including pregnant women and lactating women are exposed to AFB1 via contaminated diets while infants are exposed via breast milk, complementary and/or weaning foods including maize and peanuts. Recent AFB1 exposure is reflected by the presence of aflatoxin M1 (AFM1) in urine. We aimed to review methods applied in AFB1 exposure monitoring via the determination of urinary AFM1 in pregnant women, lactating women, and infants aged ≤24 months. We retrieved 9, 6, and 15 studies of pregnant women, lactating women, and infants, respectively. Urinary AFM1 was determined via high-performance liquid chromatography (HPLC) and liquid chromatography tandem mass spectrometry (LC–MS/MS) in 23% and 33% of studies, respectively. The HPLC- and LC–MS/MS-based methods involved extensive sample preparation and required technical expertise and very expensive equipment. ELISA, a simple, commercially available, reasonably priced and rapid technology, was used to determine urinary AFM1 in 40% of studies. Several major challenges and pitfalls must be addressed to achieve reliable and standardized data. The challenges include sample size, study design, collection, transportation, and storage of urine, reporting of AFM1 concentration either in crude form or after adjusting for creatinine concentration; and analytical issues including matrix effects, recovery, reproducibility, and limit of detection. The development of accessible, validated analytical methods, and guidelines for the determination of urinary AFM1 is warranted to achieve reliable and standardized data.

Figshare
Good health and well-being, Zero hunger
Mycotoxins in Agriculture and Food
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon